Prafulla C Gokhale Selected Research

Prafulla C Gokhale Research Topics

Disease

41	Neoplasms (Cancer) 10/2022 - 11/2002
8	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2011
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
3	Merkel Cell Carcinoma 10/2022 - 01/2020
3	Carcinoma (Carcinomatosis) 11/2021 - 05/2004
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 02/2016
3	Breast Neoplasms (Breast Cancer) 01/2007 - 05/2004
2	Malignant Mesothelioma 01/2021 - 12/2020
2	Rhabdoid Tumor (Rhabdoid Tumors) 01/2020 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 12/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012 - 03/2004
1	Neuroendocrine Carcinoma 10/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2022
1	Edema (Dropsy) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Glioma (Gliomas) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 03/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Medullary Carcinoma 12/2019
1	Systemic Mastocytosis 11/2019
1	Medulloblastoma 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2018

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
8	Antisense OligonucleotidesIBA 01/2009 - 03/2004
7	LErafAONIBA 01/2009 - 11/2002
6	Phosphotransferases (Kinase)IBA 01/2022 - 03/2011
6	Pharmaceutical PreparationsIBA 01/2020 - 03/2004
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2020
4	Liposomes (Liposome)IBA 01/2009 - 03/2004
3	Messenger RNA (mRNA)IBA 09/2021 - 03/2006
3	Immune Checkpoint InhibitorsIBA 01/2021 - 02/2016
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 03/2011
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2011
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2009
3	OligonucleotidesIBA 01/2007 - 05/2004
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2022 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2006
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2021
2	Biological ProductsIBA 03/2020 - 01/2019
2	UbiquitinIBA 01/2020 - 12/2017
2	Therapeutic UsesIBA 01/2019 - 05/2004
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2018 - 01/2009
2	Antineoplastic Agents (Antineoplastics)IBA 08/2011 - 10/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 08/2011 - 03/2011
2	Sirolimus (Rapamycin)FDA Link 08/2011 - 11/2006
2	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 05/2011 - 10/2010
1	Polycomb Repressive Complex 2IBA 10/2022
1	capmatinibIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	merestinibIBA 01/2022
1	QuinazolinonesIBA 01/2022
1	Viral ProteinsIBA 01/2022
1	milademetanIBA 01/2022
1	PanobinostatIBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	abemaciclibIBA 01/2021
1	ChromatinIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	LY3214996IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	LY3023414IBA 01/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	Histone DemethylasesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Atovaquone (Mepron)FDA Link 12/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2020
1	Immunoconjugates (Immunoconjugate)IBA 03/2020
1	monomethyl auristatin EIBA 03/2020
1	HomoharringtonineIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	NEO2734IBA 01/2020
1	Ubiquitin-Conjugating EnzymesIBA 12/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2019
1	Proteasome InhibitorsIBA 12/2019
1	Sorafenib (BAY 43-9006)FDA Link 11/2019
1	midostaurinIBA 11/2019
1	tyrosine receptor (receptor, tyrosine)IBA 11/2019
1	quizartinibIBA 11/2019
1	crenolanibIBA 11/2019
1	avapritinibIBA 11/2019
1	gilteritinibIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	ATSP-7041IBA 01/2019
1	Histones (Histone)IBA 01/2019
1	RG7388IBA 01/2019
1	Small Molecule LibrariesIBA 01/2019
1	CytokinesIBA 01/2018
1	Ubiquitin CIBA 12/2017
1	LigandsIBA 02/2016

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2007
3	Immunotherapy 01/2021 - 01/2021
2	Radiotherapy 01/2021 - 02/2006
2	Drug Therapy (Chemotherapy) 01/2020 - 03/2004